speb/financial-data huggingface dataset:
ALKALI.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 3216000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 110226000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 8234000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Research And Development: 3250000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 11386000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 15227000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 14746000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
ALKALI.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 198842000.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
ALKALI.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 93090000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 187736000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 174249000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 88290000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 6331000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 10148889.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.90
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 101825000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 643000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4092000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 101825000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 419446000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 100064000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 392065000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 178925000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 178925000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 383353000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 7215000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 7215000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 10148889.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.90
ALKALI.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — EBIT: -4887000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — EBITDA: 2328000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3753000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 398018000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 87672000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 4247000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 4247000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 282740000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 600421000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 6331000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 2050000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 2050000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 180332000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Income: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -4247000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4247000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 398018000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 419446000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 38494000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 19464000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 9112000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2328000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Operating Income: -5418000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 187736000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 10182506.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 16943000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 19700000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 317621000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1483000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 531000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 34820000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 398018000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3449000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Payables: 174249000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 6935000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -9134000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 100064000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7215000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Research And Development: 2530000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 11686000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 15439000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 10182506.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 419446000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 419446000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 834908000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 421496000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 180975000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 419446000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 193154000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 415462000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 442843000.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 32109000.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
ALKALI.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
ALKALI.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 8712000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 96589000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 249112000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 10164964.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -1.37
ALKALI.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 161937000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 6797000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 6797000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 10164964.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.37
ALKALI.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — EBIT: -7009000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — EBITDA: -212000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 3774000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 87175000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 6917000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6917000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Income: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -6917000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6917000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -212000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Operating Income: -9414000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 249112000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 2405000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 31109000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -13926000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 161937000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 6797000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Research And Development: 3063000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 19374000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 23148000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 258526000.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
ALKALI.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -10727600000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -464400000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Amortization: 518900000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 518900000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 9671700000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 30000000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 2291800000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 2736000000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 1800000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1265900000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 20812200000.00
ALKEM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 2475800000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 19310400000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Held To Maturity Securities: 1050800000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 11200000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Interest Income: 1226800000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 1226800000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 8820700000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1372500000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -192900000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 22554200000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: 0.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: 0.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 79200000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 1011300000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 3197200000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2736000000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Preferred Stock Issuance: 0.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 6187000000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 7899700000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 64300000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 64300000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -192900000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 14048600000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 65938900000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Sale Of Intangibles: 0.00
ALKEM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 10490300000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 12966100000.00
ALKEM.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 8820700000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 115300000.00
ALKEM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 1343400000.00
ALKEM.NS income_statement (annual, 2022-03-31) — Write Off: 149600000.00
ALKEM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 51238600000.00
ALKEM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 114403500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 11650300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 21321800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -11210800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -438200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Amortization: 300900000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 300900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 1232600000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 2600100000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 119565000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Basic EPS: 82.31
ALKEM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 2321800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 8786000000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -2329100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 895300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2738000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 11431600000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -5295200000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 742100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1995900000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 4734100000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Change In Payable: 145100000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -2117200000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 3267700000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 345200000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 90452900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3102700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 49823200000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 87296800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 192000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 13071500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 13263500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 37071500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 3727500000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Depreciation: 2803300000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 3104200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 3104200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 2803300000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 119565000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 82.31
ALKEM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 9841700000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 2000000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 1900000.00
ALKEM.NS income_statement (annual, 2023-03-31) — EBIT: 13985200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — EBITDA: 17089400000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 71000000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 2738000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1619400000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -17608200000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 16377000000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 14495900000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -310500000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 123600000.00
ALKEM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 2991400000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Goodwill: 4131700000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 4925500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 21760000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 36346300000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Gross Profit: 64580300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Held To Maturity Securities: 1426700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 21700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Interest Expense: 937500000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 937500000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Interest Income: 1711400000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 1711400000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -904600000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 1469100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Inventory: 26075300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 103524400000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 1128400000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 5646200000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 1614800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1369100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 703300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 0.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 703300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 3693600000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 21709900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 3897100000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Minority Interests: -226400000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 10333500000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -118800000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Income: 9841700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 9841700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 10068100000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 9841700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 9841700000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 13047700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 10068100000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Interest Income: 637800000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 1954500000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -12784800000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -95000000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 637800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 25135500000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -2297100000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Preferred Stock Issuance: 1614800000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -12689800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 85527400000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 88000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 13025000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 815300000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 17955900000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Normalized Income: 10510638000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 16825000000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Operating Income: 13341700000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 114403500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 119565000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 221100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 6000000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 793800000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -655300000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 123300000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 11062400000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 3496800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1378600000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1970100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 8693600000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Other Special Charges: 1153400000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Payables: 15383500000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Preferred Stock Issuance: 1614800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 7134900000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Pretax Income: 13047700000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 48800000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -2175300000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -2329100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 8058400000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 49823200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 3104200000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 97800000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 97800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 17909400000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 70519700000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 4129800000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 32000000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 13150800000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 16142200000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 119565000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -1175100000.00
ALKEM.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 0.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 90452900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 85527400000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -197562000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Tax Provision: 2979600000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.23
ALKEM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -2733900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 137566500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 90452900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 13966800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 94350000000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Total Expenses: 101061800000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 43216500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 50269700000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 6145000000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 136100000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 234400000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -866500000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -866500000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 1639900000.00
ALKEM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 50225300000.00
ALKEM.NS income_statement (annual, 2023-03-31) — Write Off: 170400000.00
ALKEM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 54226100000.00
ALKEM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 124392400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 17481200000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 22528100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -13773400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -913500000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Amortization: 317800000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 317800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 2409800000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 119565000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Basic EPS: 150.19
ALKEM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2738000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 10333100000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2592900000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 2044400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 4550700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 42697200000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -5404900000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 4550700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -734000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 5252800000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -3571000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -516900000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -2054400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 103120600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1868700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 50317700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 104115800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 151800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 11739700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 11891500000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 39945500000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 1268700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Depreciation: 2675200000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 2993000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 2993000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 2675200000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 1965600000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 119565000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 150.19
ALKEM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 17957700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 1700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 1900000.00
ALKEM.NS income_statement (annual, 2024-03-31) — EBIT: 21188400000.00
ALKEM.NS income_statement (annual, 2024-03-31) — EBITDA: 24181400000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -20500000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 663100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1644000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -11450100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 16452500000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 16887800000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -153600000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 31800000.00
ALKEM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 3029000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Goodwill: 4167400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 4743200000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 23441600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 39728500000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Gross Profit: 74074700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Held To Maturity Securities: 1704000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 0.00
ALKEM.NS income_statement (annual, 2024-03-31) — Interest Expense: 957100000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 957100000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Interest Income: 2757700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 2757700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -913100000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 2392800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Inventory: 26611800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 115260300000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -10085000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 4053800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 0.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 400000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1364600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 1892600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 400000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 2292600000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 400000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 2998600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 23690400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 4023400000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Minority Interests: -156900000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 7589000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 594300000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Income: 17957700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 17957700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 18114600000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 17957700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 17957700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 20231300000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 18114600000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Interest Income: 1633600000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -10611600000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -4808900000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 400000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 1633600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 25955100000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -1868100000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Preferred Stock Issuance: 0.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -5208900000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 98377400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 258400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 15148300000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2998600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 871000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 25276400000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Normalized Income: 18937725000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 19480700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Operating Income: 19848600000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 124392400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 119565000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 214200000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 2296500000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 195400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 575800000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -1653400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 258400000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 179200000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 14241300000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 4039500000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2471700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 2075200000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 38146500000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Other Special Charges: 1246700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Payables: 22072300000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1268700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Preferred Stock Issuance: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 7784300000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Pretax Income: 20231300000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 842000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -36792500000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2592900000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 8685200000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 50317700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 2993000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 96000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 96000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -5208900000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 2205000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 83097000000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 26180900000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 724800000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 12818700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 15847700000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 119565000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -5208900000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Special Income Charges: -1246700000.00
ALKEM.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 189400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 103120600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 98377400000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -114975000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Tax Provision: 2116700000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.11
ALKEM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -4069400000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 155749000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 103520600000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 14184100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 107144000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Total Expenses: 104543800000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 48605000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 51633200000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 8659500000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 167000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 549900000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -1095000000.00
ALKEM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -1095000000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 1474100000.00
ALKEM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 64170300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 18862500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 24981100000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 1346300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 10983200000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 2416300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4125800000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 47396400000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 239100000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 114928500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 2918900000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 111092800000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 283000000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 11103200000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 11386200000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 41776000000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 1493100000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 4192000000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 5373600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 25611600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 29121800000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 127291200000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 10983200000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2133300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 1259500000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 3392800000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 3173600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 4172300000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 8236900000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 25611600000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 109554900000.00
ALKEM.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 16532600000.00